Drug Trial Radar · NCT06611423
AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment
Last checked: Nov 19, 2026Latest source record: Sep 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
10
Actual
Start
Oct 15, 2024
Primary completion
Aug 21, 2025
Study completion Aug 21, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- CTC Clinical Trial Consultants AB; Karolinska Institutet
- First posted
- Sep 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The present study is designed to test the effect of AZD3427 on renal perfusion in participants with heart failure and reduced eGFR (30 to 90 mL/min/1.73m2).
Conditions
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- Renal Impairment
Interventions
AZD3427Biological
AZD3427 SC injection to be prepared using AZD3427 diluent
AZD3427 PlaceboOther
AZD3427 Placebo
DopamineDrug
Dopamine Hydrochloride 50mg/5mL
Radiolabelled ligandOther
Injection of radioligand for PET examinations
SalineOther
Saline solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- The volumetric fraction (%) of the renal cortex with increased perfusion from baseline to Day 8, compared to placebo.Time frame: Baseline to Day 8
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Site
Solna, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.